Having recently received FDA clearance, Neural Analytics, a company out of Los Angeles, California, is now making available its Lucid M1 utrasound brain damage assessment system. The device uses transcranial Doppler ultrasound to assess blood flow within the brain and to detect damaged blood vessels. It’s intended to quickly help triage patients and speed toward diagnosis and treatment.
The Windows device is battery powered and has a touchscreen display for controls and data visualization. The algorithms the Lucid M1 uses were developed at and licensed from UCLA.
“Over the last several years, the field of interventional neurology has witnessed an innovation explosion that has fundamentally changed the way that we treat stroke to improve patient outcomes. SVIN [Society of Vascular and Interventional Neurology] has set an ambitious goal to treat every eligible stroke patients emergently with mechanical thrombectomy, but this can only be achieved if stroke patients get access to hospitals with mechanical thrombectomy capability within six hours of their symptoms,” said Dr. Dileep Yavagal, MD, Past President of SVIN, in a statement. “We are gratified that Neural Analytics will support SVIN on this important initiative as their future technologies will assist us in determining if a patient is suffering from a brain blood flow disorder like stroke, potentially leading to faster treatment and better overall outcomes for these patients.”
Via: Neural Analytics…